Volume 11 Supplement 1
Carrier model of HTLV-1 infection in humanized NOG mice
© Tezuka et al; licensee BioMed Central Ltd. 2014
Published: 7 January 2014
HTLV-1 infection leads to adult T-cell leukemia (ATL) after long latent infection period. We have established an HTLV-1-infected humanized NOG mouse model to analyze the mechanism of ATL development. Humanized mice were inoculated with Jurkat-based HTLV-1 producing cells, JEX, into peritoneal cavity to infect human T-cells with HTLV-1. Infected T-cells proliferated vigorously in infected mice and the mice died of ALT-like lymphoproliferative disorder with attenuated HTLV-1 specific immunoresponses within two to three months of infection. In contrast, when HTLV-1 producing cells were inoculated orally, infection of human T-cells was established but the proviral loads (PVL) was kept constant in small amount (0.2-9.5 copies / 100 PBMCs) without any pathological feature, even after 18 weeks post infection. The amount of antibody against HTLV-1 in the plasma of orally infected mice was equivalent to that of intraperitoneally infected mice at 2-6 weeks post infection. The titer of antibody was maintained throughout lifetime in orally infected mice but not in intraperitoneally infected mice. Furthermore, depletion of CD8 T-cells from orally infected mice by injecting anti-CD8 antibody resulted in transient increase of PVL in PBMCs, indicating the involvement of cytotoxic T-cells in the control of PVL in these mice. Thus, orally infected humanized NOG mice should provide a model system of HTLV-1 carrier to examine factors involved in the development of ATL from carrier state and play a significant role in evaluating preventive vaccine candidates and antiretroviral drugs for HTLV-1 infection.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.